chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had the active vaccination nasally last Monday on January 4th.  I am having some side effects from it.  My right hand is tingly and stiff so I am having difficulty typing and especially writing with my right hand.  I cannot complete my letters and it is almost painful and tedious to write.  My balance is a little bit off as well.  Is this normal?  I read it can attack the central nervous system so I am wondering if these side effects will go away...? I called my M.D. this a.m. and left a message.  I am not sure if anything can be done to reverse the side-effects of the vaccine.  I look forward to your response.  I work in a school and it is difficult to do my job.
Headache; chills; fatigue; extreme tenderness at site of injection; slight cough. Sunday 4:00 PM new symptoms: tender lump (maybe a cyst) in left under arm; cyst on chin; itching hands and feet.
Patient is a 55 y/o female here today for pneumococcal 23 vaccine reaction. She received this vaccine yesterday early afternoon here in clinic in LEFT deltoid. She reports feeling the typical aching later on but then felt the redness and swelling "growing." She went to ER around 730 pm (we do not have this note yet). She states they gave her benadryl and instructed her to ice it and she was sent home. She denies any fever, chills, n/v, SOB, swelling of tongue/throat. She states the redness has gone down but the swelling/pain has spread further down arm towards elbow and up to her neck and over left side of chest. 1. Local reaction to pneumococcal vaccine, initial encounter   Notes: The erythema has almost completely resolved  Discussed giving a Kenalog inj today to help with the residual swelling and she would like this  She'll continue benadryl prn - cautioned about sedation  Rec'd she take Zyrtec daily as well and cont icing  I imagine this will improve over the next few days  F/u if it does not improve  PCV23 added to "allergy" list  ER precautions discussed.
since receiving second dose of COVID vaccine in JUNE, my daughter has not had her menstrual cycle since MAY 2021
ADMINISTRATION OF VACCINE FROM AFFECTED VIALS DUE TO TEMPERATURE EXCURSTION; INCORRECT PRODUCT STORAGE; This spontaneous report received from a pharmacist concerned a 21 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 207A21A, expiry: 21-SEP-2021) dose was not reported, administered on 30-JUN-2021 for prophylactic vaccination. No concomitant medications were reported.  On 30-JUN-2021, the patient experienced administration of vaccine from affected vials due to temperature excurstion. On 30-JUN-2021, the patient experienced incorrect product storage. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the administration of vaccine from affected vials due to temperature excurstion and incorrect product storage was not reported. This report was non-serious. This case, from the same reporter is linked to 20210916553, 20210916455, 20210916129, 20210915661, 20210916910 and 20210915719.
Rash started 10pm day of vaccine - 2 am hives especially lower extremities. Reported next day. No fever, aches, dizziness, edema. Pt says he feels fine. Thinks rash has peaked. Pt picked up BENADRYL to help with itching.
Fatigue; Tingling on lips and legs sciatica like pain in legs; Tingling on legs; Tingling on lips and legs; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 49 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 26Mar2021 23:45 (Batch/Lot number: unknown) at the age of 49 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "known allergies: Fresh apples, pears, peaches, plums" (unspecified if ongoing), notes: known allergies: Fresh apples, pears, peaches, plums. Prior to vaccination, patient was not diagnosed with COVID-19. Concomitant medication(s) included: SINGULAIR; SYMBICORT; ALBUTEROL [SALBUTAMOL] inhaler. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The following information was reported: FATIGUE (non-serious) with onset 27Mar2021 08:00, outcome "not recovered", described as "Fatigue"; PAIN IN EXTREMITY (non-serious) with onset 27Mar2021 08:00, outcome "not recovered", described as "Tingling on lips and legs sciatica like pain in legs"; PARAESTHESIA (non-serious) with onset 27Mar2021 08:00, outcome "not recovered", described as "Tingling on legs"; PARAESTHESIA ORAL (non-serious) with onset 27Mar2021 08:00, outcome "not recovered", described as "Tingling on lips and legs". Therapeutic measures were not taken as a result of fatigue, pain in extremity, paraesthesia, paraesthesia oral. Additional information: Since the vaccination, the patient has not been tested for COVID-19. Facility where the most recent COVID-19 vaccine was administered: Other.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Red blotches all over arms, back, and front and back of the legs, and some on the face.  Blotches are called petechiae.
Pt. presented to clinic with blotchy rash on body & legs. Placed on medication.
Left anterior lymphadenopathy x 3 days. Dr prescribed Amoxicillin Caps 500mg PO TID x 7 days.
3/20/23 started with a sore throat in the evening. 3/21 felt bad and tested on an at home COVID-19 test, positive. Televisit with doctor who PAXLOVID on 3/22. This felt like a bad sinus infection with fatigue and weakness. Fever peaking at 102, but that only lasted a couple of days. Fatigue lasted about 11 days.
Room was very hot for mass H1N1 clinic in school. Patient waited in line prior to vaccination. Symptoms per school RN at 10:45AM- dizziness. Best friend of child taken via ambulance to ER after receiving vaccine also. Patient was pale, no diaphoresis or loss of consciousness at school. Discharged to mother at 11:27 AM-mother took child to ER. D/C from ER 4:32 PM. TC to mother 11-24-stated "child had severe allergic reaction to vaccine".
Exhaustion, muscle soreness, nausea,  chills, and fever starting around 12 hours after vaccination administered and lasting for 12 hours.  Vaccination site pain starting directly after administration and lasting 24+ hrs.
Have experienced high pitch whine in head, I believe tinnitus, continuously since 1/13. have not sought medical attention yet
Rebound COVID; COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Nurse). The reporter is the patient.  A 51-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), in Sep2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 50 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Overweight BMI 31" (unspecified if ongoing), notes: Overweight BMI 31; "Penicillin Allergy" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Codeine, reaction(s): "Known allergies: Codeine". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Aug2022, outcome "unknown" and all described as "COVID 19 Treatment"; DISEASE RECURRENCE (medically significant) with onset 26Aug2022, outcome "unknown", described as "Rebound COVID". The patient underwent the following laboratory tests and procedures: Body mass index: (unspecified date) 31, notes: Overweight BMI 31; SARS-CoV-2 test: (21Aug2022) Negative, notes: Tested negative antigen on 21Aug to return to work developed congestion the night of 26Aug; (27Aug2022) Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19, disease recurrence. Clinical information: Anti viral details: Product: COVID 19 Treatment, brand: Paxlovid , Treatment start date was 17Aug2022, Treatment stop date was 22Aug2022. Patient took Acetaminophen in 2 weeks product. Rebound COVID 19 after last Paxlovid dose on 22Aug, tested negative antigen on 21Aug to return to work developed congestion the night of 26Aug and tested antigen positive on 27Aug.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Based on the information provide and plausible temporal association, the causality between BNT162B2 and events cannot be completely excluded.
Vial was initially stored in the refrigerator from the freezer on 27-Apr-2022 and administered on 28-May-2022; Administered with vaccine that is past beyond the 30 day use; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered with vaccine that is past beyond the 30 day use) and PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator from the freezer on 27-Apr-2022 and administered on 28-May-2022) in a 50-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 056M21A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-May-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-May-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered with vaccine that is past beyond the 30 day use). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator from the freezer on 27-Apr-2022 and administered on 28-May-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered with vaccine that is past beyond the 30 day use) and PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator from the freezer on 27-Apr-2022 and administered on 28-May-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No information on concomitant medication was reported. The vial was initially stored in the refrigerator from the freezer on 27-Apr-2022 and the doses were administered on 28-May-2022. No adverse events have been reported by the 7 patients.  No information on treatment medications was reported.
He had recently been vaccinated with MMR II in May 2020 for the purpose of protection against COVID-19 disease severity and death.; This spontaneous report was received from a retired pediatrician referring to himself of unknown age. The patient's pertinent medical history, concomitant therapies and drug allergy or reactions were not reported.      In May 2020, the patient had recently been vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (strength, dose, route, lot number and expiration date were not reported) for the purpose of protection against coronavirus disease 2019 (COVID-19) disease severity and death (off label use). The outcome of off label use was unknown.   During call, the reporter pediatrician also mentioned a related published study and other anonymous patient adverse events (AEs) (which has captured in MARRS # 2008USA008539 and 2008USA006838). The reporter wanted to know if Merck was looking into potential use of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) for COVID-19.  This is one of the three reports received from the same reporter.; Sender's Comments:  US-009507513-2008USA008539: US-009507513-2008USA006838:
Initial report received from a consumer on 25 January 2012. A 35-year-old female patient, had received first intramuscular dose of IMOVAX rabies (batch number: not reported) in deltoid and 5 intramuscular shots of RIG (manufacturer: unknown and batch number: not reported) in right and left gluteal region, on 05 January 2013. The patient reported that she had some kind of infection and was undergoing 10 day antibiotic treatment for the same. She also had swollen lymph glands. On 06 January 2013, the patient experienced tingling going down both the legs. The patient also reported increase in lymph node swelling on an unspecified date and one night the patient woke up with shortness of breath which lasted for a minute. Laboratory data were not reported. Corrective treatment received by the patient was not reported. The event increase in lymph node swelling went away on an unspecified date, shortness of breath lasted for 1 minute and the outcome for the event tingling going down both the legs was unknown. Documents held by sender: None.
Left upper, outer arm, 4 cm induration with erythema. Benadryl, Motrin RTC
NOT FEELING HERSELF; RASH; TIRED; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's past medical history included has had anaphylactic shock before. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805020, and expiry: UNKNOWN) dose was not reported, administered to left arm on 15-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the subject experienced rash, not feeling herself, and tired. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the tired, rash and not feeling herself was not reported. This report was non-serious.
Tingling and numbness in both hands and feet, sharp pains in the top of the foot, and pain at injection site.
No additional AE's/PQC's were reported; reporting a temperature excursion for VARIVAX/ have been administered to several patients since the escursion; This spontaneous report has been received from an office manager and refers to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions or allergies, and concomitant medications were not reported.  On 19-AUG-2021, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) dose or frequency 1 (units not provided) (route of administration, vaccine scheme, anatomical site of vaccination were not reported; lot number T041685 has been verified to be valid, expiration date reported and established as 10-DEC-2022) as prophylaxis.   The vaccine was exposed to a temperature excursion of 11.3 Fahrenheit degrees (°F) during a time frame of 15 minutes (product storage error). There was no previous temperature excursion. No adverse events were reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2108USA006576:
Pt. received influenza vaccine in primary care office in AM, went to pharmacy and received ZOSTAVAX vaccine about 2 PM. Noticed swelling and difficulty breathing about 3 PM, rash developed at same time on face and chest. Used inhaler for breathing and came to clinic in AM. Swelling is bilateral to shins. Concerned re CHF/pulmonary edema . ZANTAC and BENADRYL given.
Patient when seated stated to pharmacy personnel she was feeling dizzy and felt as if blacking out and was sweating.
At 0847 patient reported numbness to face, lips, and throat. No SOB nor difficulty breathing. Denied pain.  No antidote nor supportive treatment given. After ~40 minutes of observation, minimal numbness and no SOB. Patient left clinic.
Patient complained of being dizzy, couldn't breath, unable to move L arm. L side of back  numb also complained of legs hurting but stated legs had hurt all week. BP 138/70 HR 81 O 2 sat 97% glucose per fingerstick 212 equal grip, PEARL, Respirators 22  Transported to local hospital via ambulance for health care
01/20/22 presents to ED for "shortness of breath, productive cough, and fever and chills". PMHx of "CLL"
It was reported that a 5 year-old male patient received IPOL and a Tripedia vaccination on 03/29/2001. Reportedly, the next day the patient developed a fever of 102 F and lethargy. One week later, he dedveloped sinusitis and a reccurrence of ITP (Idiopathic thrombocytopenic purpura). From FOLLOW-UP telephone contact on 08/15/2001 with vaccinatin physician it was stated that the patient received a DTP vaccination in 1977 (Tetramune) and developed ITP a couple weeks later. After the resolution of the ITP platelets counts were discontinued "On 03/29/2001, (patient) was given a DAPT vaccine in the left arm He developed bruises and a platelet count on 04/05/2001 was 55,000. He was again followed by Hospital and platelet counts have since returned to normal without treatment.
I arrived in the ER on April 14, 2021, presenting with abdominal and flank pain. CT revealed multiple left renal infarcts and liver infarcts and an incidental finidng of lung nodules. I was started on heparin and admitted to the hospital, released on April 16, 2021.
sweats, nausea, explosive watery diarrhea and syncope.  head injury from fall without concussion.  no formal evaluation done. fatigue, chills, muscle aches/ cramps
Patient had COVID vaccine on 1/16/21 - has been having fevers, fatigue, chills headaches and lightheadness - sometimes she feels like she is going to pass out - nausea - She had a negative Covid test on 1/18/21
mom stated rt arm looks as if it has been scalded;warm to touch, very painful;MD sent atarax, but mom plans to take child to ER;mom thinks pt has an infect;
Pt observed following inj./ After 15 minutes pt appeared to be having seizure activity. Observed until able to leave with grandmother of her own accord.
CHILLS.....SORE ARMS-LEGS...LOW GRADE FEVER 100.2
I was diagnosed with breast cancer recently, one year after the vaccine. Not sure if the vaccine was the cause but I went in for a routine mammogram a few weeks after the vaccine. There was an area of concern but they did not worry about it to much. I just recently now went in for the 6 month check and that same area was now biopsied and came back positive for breast cancer. It is on the same side as where I got my vaccine.
Patient felt unwell ("flu-like" symptoms) on day 2-3 post-injection with some arm soreness. Patient felt better on day 3, but noticed a slight rash and dull pain at the base of the deltoid muscle (much lower than injection site) a few days ago. He said the area did not itch, arm movement was not restricted or limited, no pain upon touching the area. He also said the area did not feel warm to the touch. He was just concerned about the light rash and dull pain since it has been 2 weeks post-injection.
Shingles. Both times I got a Covid-19 booster. First, last spring (2022) on my side, then in January in my ears. I?ve lost my hearing in one ear.
Fever, body aches. Headache, and Hot, red,  rash below injection site.
I26.99 ACUTE PULMONARY EMBOLISM 4/13/2023 CHF EXACERBATION, UNSPECIFIED I63.531 ACUTE STROKE DUE TO OCCLUSION OF RIGHT POSTERIOR CEREBRAL ARTERY 5/4/2023 CHF EXACERBATION, UNSPECIFIED
I started with what seemed to be cold symptoms on 06/23/2022, I had a "drippiness", scratchy throat when I went to bed that evening. I had been around my granddaughter who had what she though was allergies but she ended up testing positive for COVID-19. The next day I woke up feeling "icky". I felt the same on 06/25/2022 and I kept falling asleep, so that was something new. I felt the same on 06/26/2022, symptoms included coughing, stuffy and runny nose as well as fatigue. I took a home test which came back positive. Still having cough, congestion, some stuffiness, but I am feeling a little better.
Mom presented on 7/22/08 concerned about right arm swelling over deltoid for child.  Some pain initially, but had resolved at presenting.
Three months after receiving the second dose of the vaccine, I was admitted into the ICU (September 7th, 2021) and treated for being in DKA. My blood sugar was +500, and A1C was 12.6 and estimated by doctors that my average blood sugar for the past 3 months was 300. My thyroid hormone levels also pointed to hypothyroidism. I was given 2 kinds of insulin and levothyroxine to take daily. Later, I was officially diagnosed with Type 1 Diabetes and Hashimotos disease.
Case number PHEH2014US019871, is an initial spontaneous report from a medical assistant received on 01 OCT 2014. This report refers to a 20-year-old female patient (nurse). Historical conditions were not reported. No concomitant medication was reported. It was reported that the FLUVIRIN 2014/2015 (batch number: 141901) vaccine leaked onto patient (nurse) skin with no reaction noted on 30 SEP 2014. No adverse reaction reported following the inadvertent exposure to vaccine.
no adverse event; Patient received first dose Moderna COVID-19 vaccine Bivalent from a vial with pink cap; This spontaneous case was reported by a nurse and describes the occurrence of WRONG PRODUCT ADMINISTERED (Patient received first dose Moderna COVID-19 vaccine Bivalent from a vial with pink cap) and NO ADVERSE EVENT (no adverse event) in a patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     It was unknown if patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine.     In 2023, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. In 2023, the patient experienced WRONG PRODUCT ADMINISTERED (Patient received first dose Moderna COVID-19 vaccine Bivalent from a vial with pink cap). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Patient received first dose Moderna COVID-19 vaccine Bivalent from a vial with pink cap) and NO ADVERSE EVENT (no adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Patient received first dose Moderna COVID-19 vaccine Bivalent from a vial with pink cap).    Patient was never vaccinated with any other COVID-19 vaccine in the past. Patient age was between 6 months to 5 years.  Concomitant product use was not provided by the reporter.  It was reported that the incidents started in May-2023 and they just noticed it (Lot number 215K22A and Exp. Date: unknown), (Lot number 216K22A and Exp. Date: unknown).  Treatment information was not provided.  This case contains information about patient 1 out of 11 patients.   This case was linked to US-MODERNATX, INC.-MOD-2023-740035, US-MODERNATX, INC.-MOD-2023-740036, US-MODERNATX, INC.-MOD-2023-740039, US-MODERNATX, INC.-MOD-2023-740042, US-MODERNATX, INC.-MOD-2023-740040, US-MODERNATX, INC.-MOD-2023-740049, US-MODERNATX, INC.-MOD-2023-740048, US-MODERNATX, INC.-MOD-2023-740057, US-MODERNATX, INC.-MOD-2023-740077 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-740039:Patient 8 out of 11 US-MODERNATX, INC.-MOD-2023-740036:Patient 02 out of 11 US-MODERNATX, INC.-MOD-2023-740035:Patient 7 out of 11 US-MODERNATX, INC.-MOD-2023-740057:Patient 05 out of 11 US-MODERNATX, INC.-MOD-2023-740042:Patient 9 out of 11 US-MODERNATX, INC.-MOD-2023-740040:Patient 03 out of 11 US-MODERNATX, INC.-MOD-2023-740049:Patient 11 out of 11 US-MODERNATX, INC.-MOD-2023-740048:Patient 04 out of 11 US-MODERNATX, INC.-MOD-2023-740077:Patient 06 out of 11
Severe pain at injection site, severe HA for 24 hours, fever, joint pain, fatigue, body aches